The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

LifePoint Hospitals Inc

Nasdaq: LPNT
Last

(U.S.) $71.99

Today's change+0.14 +0.19%
Updated December 22 4:00 PM EST. Delayed by at least 15 minutes.
 

LifePoint Hospitals Inc

Nasdaq: LPNT
Last

(U.S.) $71.99

Today's change+0.14 +0.19%
Updated December 22 4:00 PM EST. Delayed by at least 15 minutes.

LifePoint Hospitals Inc up (U.S.)$0.14

LifePoint Hospitals Inc closed up Monday by (U.S.)$0.14 or 0.19% to (U.S.)$71.99. Over the last five days, shares have gained 2.75% and 36.24% year to date. Shares have outperformed the S&P 500 by 27.37% during the last year.

Key company metrics

  • Open(U.S.) $72.05
  • Previous close(U.S.) $71.85
  • High(U.S.) $72.61
  • Low(U.S.) $71.67
  • Bid / Ask(U.S.) $68.20 / (U.S.) $75.87
  • YTD % change+36.24%
  • Volume218,303
  • Average volume (10-day)386,445
  • Average volume (1-month)345,559
  • Average volume (3-month)495,579
  • 52-week range(U.S.) $50.18 to (U.S.) $76.50
  • Beta1.01
  • Trailing P/E24.31×
  • P/E 1 year forward22.16×
  • Forward PEG1.47×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.96
Updated December 22 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+3.50%

Based on its net profit margin of 3.50%, LifePoint Hospitals Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.25%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue1,1661,0471,007953
Total other revenue--------
Total revenue1,1661,0471,007953
Gross profit427396375355
Total cost of revenue739651632598
Total operating expense1,120981956891
Selling / general / administrative243222211200
Research & development--------
Depreciation / amortization69616159
Interest expense (income), net operating--------
Unusual expense (income)120--1
Other operating expenses, total2815197
Operating income46675162
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax46675162
Income after tax29423838
Income tax, total17251324
Net income28393736
Total adjustments to net income--------
Net income before extra. items28393736
Minority interest-1-3-1-2
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items28393736
Inc. avail. to common incl. extra. items28393736
Diluted net income28393736
Dilution adjustment0------
Diluted weighted average shares47474848
Diluted EPS excluding extraordinary itemsvalue per share0.590.840.780.75
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.750.840.780.77